What's new

Date Content
29/03/2018 Orphan designation: Expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue (darvadstrocel) for the: Treatment of anal fistula, 08/10/2009, Positive (updated)
29/03/2018 Human medicines European public assessment report (EPAR): influenza vaccine (split virion, inactivated), IDflu, influenza vaccine (split virion, inactivated), Influenza, Human, Immunization, 24/02/2009, 13, Withdrawn (updated)
28/03/2018 Orphan designation: Recombinant fusion protein linking coagulation factor VIIa with albumin for the: Treatment of congenital factor VII deficiency, 07/10/2013, Positive (updated)
28/03/2018 Orphan designation: Alpha1-proteinase inhibitor (inhalation use) for the: Treatment of cystic fibrosis, 14/09/2007, Positive (updated)
28/03/2018 Orphan designation: Human alpha1-proteinase inhibitor for the: Treatment of emphysema secondary to congenital alpha1-antitrypsin deficiency, 09/07/2001, Positive (updated)
28/03/2018 Orphan designation: C1-esterase-inhibitor human for the: Treatment in solid organ transplantation, 12/10/2017, Positive (updated)
28/03/2018 Orphan designation: Recombinant fusion protein linking human coagulation factor IX with human albumin for the: Treatment of haemophilia B, 04/02/2010, Positive (updated)
28/03/2018 Procedures for monograph and list entry establishment (updated)
28/03/2018 Herbal medicinal product: Herniariae herba, Herniariae herba, D: Draft under discussion (updated)
28/03/2018 Herbal medicinal product: Menyanthidis trifoliatae folium, Menyanthidis trifoliatae folium, D: Draft under discussion (updated)